Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.
Saved in:
| Title: | Atezolizumab in High-Risk Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial. |
|---|---|
| Authors: | Haddad R; Dana-Farber Cancer Institute, Boston, Massachusetts., Fayette J; Centre Leon Berard, Département d'Hématologie et d'Oncologie, Lyon, France., Teixeira M; IPO de Coimbra, Servico de Oncologia Medica, Coimbra, Portugal., Prabhash K; Tata Memorial Hospital, Department of Medical Oncology, Mumbai, India., Mesia R; Catalan Institute of Oncology, B-ARGO Group, IGTP, Badalona, Catalonia, Spain., Kawecki A; National Research Institute of Oncology, Warsaw, Poland., Dechaphunkul A; Unit of Medical Oncology, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand., Dinis J; IPO do Porto, Servico de Oncologia Medica, Porto, Portugal., Guo Y; Shanghai East Hospital, Tongji University, Shanghai, China., Masuda M; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Hsieh CY; China Medical University Hospital, Oncology and Hematology Office Critical Care Center, Taichung, Taiwan., Ghi MG; Veneto Institute of Oncology, IRCCS, Padua, Italy., Vaz de Melo Sette C; Faculdade de Medicina do ABC-FMABC, Santo André, Brazil., Harrington K; The Royal Marsden Hospital/The Institute of Cancer Research, London, United Kingdom., Tahara M; National Cancer Center Hospital East, Kashiwa, Japan., Saba NF; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia., Lau A; Genentech, Inc, South San Francisco, California., Jiang T; Genentech, Inc, South San Francisco, California., Yan Y; Genentech, Inc, South San Francisco, California., Ballinger M; Genentech, Inc, South San Francisco, California., Kaul M; Genentech, Inc, South San Francisco, California., Matheny C; Genentech, Inc, South San Francisco, California., Cuchelkar V; Genentech, Inc, South San Francisco, California., Wong DJ; Division of Hematology-Oncology, University of California Los Angeles (UCLA). |
| Source: | JAMA [JAMA] 2025 May 13; Vol. 333 (18), pp. 1599-1607. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1538-3598 |
|---|---|
| DOI: | 10.1001/jama.2025.1483 |
